Advertisment

Holguín Region in Cuba shows a gradual decrease in COVID-19 positive cases

Holguín Region in Cuba witnesses a gradual decrease in COVID-19 cases while emphasizing the importance of sustained awareness and precautions. With only seven positive cases this week compared to 22 in the previous week, the province aims to protect vulnerable groups, including children, the elderly, and immunocompromised individuals from the SARS-CoV-2 virus. Additionally, Holguín has recorded a prevalence rate of 0.5 per 100,000 people and continues its efforts to vaccinate 90% of the population and maintain coverage for the third dose.

author-image
Medriva Newsroom
New Update

NULL

Advertisment

To sustain a steady decline in cases, the Cuban province of Holgun recorded seven positive cases this week as opposed to 22 in the week before. However, health officials stress the need to sustain the awareness of the threat of infection with the SARS-CoV-2 virus or other respiratory viruses that are currently circulating in the area, with a high prevalence in more vulnerable groups, such as children, the elderly, and patients who are immunocompromised individuals.

Advertisment

As per a review of the province's medical and hygienic status for the period from June 12 to June 18, 71.4 percent of all identified cases were native, with an average of one diagnosed each day, for a prevalence rate of 0.5 per 100,000 people.

In this manner, Holguin acquired 16,000 COVID-19 patients in 2022, with a low number in June, when it totaled 35 in the first 19 days, of which 29 were native and 6 were imported from other countries. 

Along with combating and controlling the epidemic, the province takes on the COVID-19 vaccination to guarantee that 90% of the populace has a full program, and all municipalities maintain coverage for the third dose, which will increase to the extent that the interventions are finished, following the interdose space in the major interventions (massive, to Groups II and III in pediatric age, to the allergic population, among others).

CU
Advertisment
Chat with Dr. Medriva !